Buspirone Hydrochloride
- Product NDC
- 70518-2803
- 11-digit product format
- 705182803
- Labeler code
- 70518
- Product ID
- 70518-2803_d7317168-41c3-1e3f-e053-2a95a90abdd4
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Buspirone Hydrochloride
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA210907
- Marketing category
- ANDA
- Marketing start
- 2020-07-01
- Marketing end
- 0000-00-00
- Substance
- BUSPIRONE HYDROCHLORIDE
- Active strength
- 30 mg/1
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 70518-2803 | BUSPIRONE HYDROCHLORIDE TABLET [REMEDYREPACK INC.] | 5 | Legacy NDC | 20250403_c8a58d3b-cf61-4a17-a3fa-3bd78539a69c.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70518-2803-0 | 70518280300 | 30 TABLET in 1 BLISTER PACK (70518-2803-0) | 30 tablet | 2020-07-01 | 0000-00-00 | No | No | Current |